Mukund Iyengar, Founder and CEO of Jori, shared a post on X:
“Cancer survival in the U.S. just crossed 70%.
It was 63% in the 1990s.
That gap is 4.8M people which are alive today.
This one chart captures survival gains across 29 cancer types.
The wins are real.
So is the unfinished work.
- CML: 31% become 72%
- Multiple myeloma: 32% become 62%
- Kidney: 59% become 82%
- Metastatic melanoma: 16% become 35%
- Childhood all: 80% become 92%
But some cancers barely moved.
Cervical cancer outcomes actually worsened.
None of this is abstract progress, though.
These are birthdays, grandkids, and years of life returned.
This is what funded science does.
Next time someone asks if cancer research works, show them this (full) chart.
Source: ACS Cancer Statistics 2026 – SEER – via Jori”
Other articles on OncoDaily.